Lucid Diagnostics closes $21.95M senior secured convertible notes private placement; repays 2023 note

Lucid Diagnostics Inc.

Sold $21.95M principal amount Senior Secured Convertible Notes, net proceeds $18.3M after repaying 2023 note.
Used ~$3.6M to redeem 2023 Convertible Note (7.875% interest, $5 conversion price) with ~$2.7M outstanding principal.
Notes secured by substantially all assets; subsidiaries guarantee obligations.
Company granted registration rights for underlying common shares; must file resale statement within 120 days.
Notes convertible into common stock; terms per November 12, 2024 filing.

item 1.01 item 1.02 item 2.03 item 3.02 item 3.03 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.